cefotiam has been researched along with Sepsis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (85.71) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banks, SM; Cui, X; Eichacker, PQ; Gerstenberger, E; Hartung, T; Karzai, W; Mehlhorn, B; Natanson, C; Reinhart, K; Straube, E | 1 |
| Akashi, F; Hara, K; Ichimura, T; Inoue, M; Saito, A; Sawatari, K; Shigeno, Y; Suzuyama, Y; Watanabe, K; Yamaguchi, K | 1 |
| Kageyama, S; Kamio, N; Kataoka, Y; Katayama, N; Koh, T; Minami, N; Ono, T; Ota, C; Tanaka, I; Uno, N | 1 |
| Aizawa, M; Chiba, Y; Fukushi, K; Haneda, Y; Kawamura, S; Kawatsu, S; Komatsu, Y; Nara, H; Ohmi, T; Okamoto, K; Sakata, Y; Segawa, M; Tanabe, K; Yamagata, A; Yanagiya, S; Yoshida, Y | 1 |
| Bertrand, A; Beucler, A; Borsa, F; Bryskier, A; Dusehu, E; Humbert, G; Janbon, F; Lafaix, C; Modai, J; Veyssier, P | 1 |
| Nishimura, T; Tabuki, K; Takashima, T | 1 |
| Bauer, I; Berger, HD; Buhl, C; Ezold, R; Goedecke, A; Morawietz, I; Tauchnitz, C | 1 |
7 other study(ies) available for cefotiam and Sepsis
| Article | Year |
|---|---|
Protection with antibody to tumor necrosis factor differs with similarly lethal Escherichia coli versus Staphylococcus aureus pneumonia in rats.
Topics: Administration, Inhalation; Animals; Antibodies; Bronchoalveolar Lavage Fluid; Cefotiam; Cephalosporins; Escherichia coli; Escherichia coli Infections; Injections, Intraperitoneal; Interleukin-6; Intubation, Intratracheal; Leukocyte Count; Lymphocyte Count; Male; Neutrophils; Oxygen; Oxygen Consumption; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Rats; Rats, Wistar; Sepsis; Staphylococcus aureus; Survival Analysis; Tumor Necrosis Factor-alpha | 2003 |
[A case report of Vibrio vulnificus infection with successful treatment].
Topics: Cefotaxime; Cefotiam; Humans; Male; Middle Aged; Sepsis; Vibrio Infections | 1984 |
[Clinical investigation of cefotiam in combination with aminoglycoside or (and) penicillin against complicated infections with hematopoietic disorders].
Topics: Adolescent; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cefotiam; Drug Therapy, Combination; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Penicillins; Pneumonia; Sepsis | 1984 |
[Clinical evaluation of cefotiam in internal medicine].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefotaxime; Cefotiam; Drug Evaluation; Female; Hematologic Diseases; Humans; Male; Middle Aged; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1982 |
[Evaluation of the clinical activity of cefotiam (SCE 963). Multicentric study in 7 centers].
Topics: Adolescent; Adult; Age Factors; Aged; Bacterial Infections; Cefotaxime; Cefotiam; Child; Child, Preschool; Female; Humans; Infant; Male; Middle Aged; Respiratory Tract Infections; Sepsis; Skin Diseases, Infectious; Urinary Tract Infections | 1983 |
[Pharmacokinetic and clinical studies of cefotiam in mature neonates].
Topics: Cefotaxime; Cefotiam; Female; Half-Life; Humans; Infant, Newborn; Infusions, Intravenous; Injections, Intravenous; Kinetics; Male; Pneumonia; Sepsis | 1986 |
[Microbiologic and clinical significance of cefotiam].
Topics: Adult; Aged; Bacteria; Bacterial Infections; Cefotaxime; Cefotiam; Drug Resistance, Microbial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Sepsis; Surgical Wound Infection; Urinary Tract Infections | 1985 |